The Globe and Mail
Bookmark
Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file ...
This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Inside the Market’s roundup of some of today’s key analyst actions
The near-term outlook for
Organigram Holdings Inc. (OGI-T) “remains challenged” as revenues “continue to stagnate,” according to Canaccord Genuity analyst Matt Bottomley.
After the Moncton-based company reported weaker-than-anticipated first-quarter financial results on Tuesday before the bell, Mr. Bottomley lowered his rating for its shares to “hold” from a “speculative buy” previously.